Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Top ACR Priorities in 2017 Include Drug Costs, MACRA

Kelly Tyrrell  |  January 4, 2017

Forming a Plan
The ACR’s yearly priorities result from “extensive discussion among Government Affairs Committee members and other leaders,” in conjunction with ACR staff and consultants, Dr. Worthing says. “We look at the landscape in Washington and across states, at initiatives being supported by our coalition partners and at what’s important to our specialty, and come up with a yearly plan.”

The process spans two-and-a-half months; then in February, the GAC will present comprehensive policy statements to the ACR Board of Directors.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Additionally, this year, Dr. Worthing says, the ACR, “like all physician groups,” will be monitoring potential changes to the Affordable Care Act, including its possible repeal.

“The most important piece [with regard to] the Affordable Care Act is making sure our patients and as many Americans as possible stay insured and stay protected by health insurance,” he says. “It’s especially true in rheumatology, where our patients often utilize extremely expensive medications, which are unaffordable without the benefit of insurance.”

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

__________________________________________________________________________

Kelly April Tyrrell writes about health, science and health policy. She lives in Madison, Wis.

Page: 1 2 | Single Page
Share: 

Filed under:Practice SupportProfessional Topics Tagged with:ACR Government Affairs Committeefederal administrationGACMACRAMedicarePatients’ Access to Treatment ActRISE registry

Related Articles

    Legislative Successes in 2017: Rheumatologists lead the push in Congress for access to care, research funding, transparency in drug pricing

    December 20, 2017

    SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding. In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and…

    The American College of Rheumatology’s Legislative Successes of 2017

    January 19, 2018

    SAN DIEGO—The 2017 ACR/ARHP Annual Meeting, Nov. 3–8, presented opportunities to highlight its 2017 legislative advocacy victories, some of which were resolved just weeks before the conference began, as well as issues that are still outstanding. In the session, Legislative & Regulatory Update 2017, Angus Worthing, MD, chair of the ACR’s Government Advocacy Committee and…

    The RISE Registry: A Powerful Collaboration Tool for Clinicians & Researchers

    March 21, 2019

    Practice-based evidence, like that in the RISE registry, can be used to describe trends in patient care, look at comparative effectiveness of interventions and much more.

    The RISE Registry Delivers Practice-Based Evidence to Rheumatologists

    April 15, 2019

    The advent of quality-based healthcare, such as the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), requires rheumatology professionals to demonstrate their practice is based on interventions supported by the best available evidence and that their practice, in turn, provides quality care. These requirements have increased the need for methods to measure and quantify…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences